Randol R. Spaulding, CEO
As the CEO of Spaulding Clinical Research, Mr. Spaulding is responsible for business development and operations for the entire facility, using his Six Sigma management skills and advanced cardiac safety and technology experience to create a Phase I facility unlike any other.
Previously, Randy was the Vice President of Clinical Research at Mortara Instrument, where he oversaw product development, support, sales and marketing of Cardiac Safety products for the clinical research market. He received his B.S. in Biomedical Engineering from Marquette University, where he also completed coursework for his M.S.E.E.
Mr. Spaulding also worked for GE Medical Systems for more than six years, where he served as the General Manager of Global Cardiology Services and became a Six Sigma Master Black Belt. While with GE, he developed a Web-based Holter Data Acquisition and Review System for which he received the GE Medical Systems Global Technology 2000 Patent Award. He also completed intense senior management training at the Jack Welch Center in Crontonville, New York. Randy has been published numerous times and has presented at many scientific conferences, specifically related to the topic of cardiology and QT interval measurements. He is also the recipient of the State of Wisconsin's Governor's Best New Product of the Year Award, and the Mortara Instrument's MVP for Clinical Research.
Click here to download full CV.
Jay W. Mason, MD, Chief Medical Director
At Spaulding Clinical Research, Dr. Mason applies his more than 30 years of experience in cardiac care and safety to oversee all aspects of clinical testing - from the technicians to the technology to the volunteers - to ensure the highest standards of quality.
Dr. Mason most recently served as Medical Director and Director of R&D at Covance Cardiac Safety Services from April 2003 to April 2007. He graduated from Princeton University and obtained his medical degree from the University of Pennsylvania. Dr. Mason trained in Medicine and Cardiovascular Diseases at Stanford University Medical Center, where he was a member of the faculty from 1975 to 1983, and served as Director of the Cardiac Arrhythmia Service and Co-Director of the Cardiac Catheterization Laboratories.
Dr. Mason became Chief of Cardiology at the University of Utah in 1983, where he was a Primary Investigator for two major NIH-funded international clinical trials and an NIH-funded Specialized Center of Research in Sudden Death. In 1999, he was appointed Chairman of the Department of Medicine at the University of Kentucky. He remains a faculty member at the latter two institutions. Dr. Mason's clinical, teaching and research emphasis is in cardiac arrhythmias, repolarization and electrophysiology. He has been awarded more than $29M in NIH support during his research career, and is the author of over 400 publications.
Click here to download full CV.
Daniel S. Selness, RN, BA, MBA, Vice President of Clinical Operations
Daniel Selness is a research executive with over 15 years of experience in the operational management of clinical research for the pharmaceutical industry, with approximately 11 years focused largely in Phase I. Dan's previous experiences include working both in a Phase I research unit in various capacities as well as working on the sponsor side in the Clinical Pharmacology Departments of two of the Top 15 Pharmaceutical companies in the world.
Over the years, Dan has played an integral role in the design, authoring, placement, management, and overall direction of approximately 450 Phase I trials including First in Human studies, ADME, Bioavailability/Bioequivalence, Drug-Drug Interactions, as well as special populations and a number of definitive TQT studies.
Click here to download full CV.